Weilheim, Germany

Ulrich Pessara


Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2002-2007

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Ulrich Pessara: Innovator in Human Protein Production

Introduction

Ulrich Pessara is a notable inventor based in Weilheim, Germany. He has made significant contributions to the field of biotechnology, particularly in the production of human proteins. With a total of 6 patents to his name, Pessara's work has the potential to impact pharmaceutical development significantly.

Latest Patents

Pessara's latest patents include innovative processes for the identification and production of human cell lines that can produce human proteins through endogenous gene activation. One of his key inventions focuses on a method for selecting human cells that can generate human proteins in economically feasible quantities, suitable for pharmaceutical compositions. Another important patent involves human cells capable of producing erythropoietin (EPO) due to the activation of the endogenous EPO gene. This invention not only outlines the production of EPO-producing cells but also details DNA constructs for gene activation and large-scale production methods.

Career Highlights

Ulrich Pessara is currently associated with Roche Diagnostics GmbH, a leading company in the field of diagnostics and biotechnology. His work at Roche has allowed him to explore and develop groundbreaking technologies that enhance the production of essential human proteins.

Collaborations

Pessara has collaborated with esteemed colleagues such as Michael Brandt and Reinhard Franze. These partnerships have fostered an environment of innovation and have contributed to the advancement of their shared goals in biotechnology.

Conclusion

Ulrich Pessara's contributions to the field of human protein production through innovative patenting and collaboration highlight his role as a key figure in biotechnology. His work continues to pave the way for advancements in pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…